Medication Adherence With Telehealthcare Medication Therapy Management

Inclusion Criteria: * Age 12 through 35 years * Speaks English or Spanish * Physician diagnosed asthma (without any other co-morbid pulmonary disease) * Prescribed ICS treatment for at least 3 months prior to screening * Adherence to Refills and Medication Scale (ARMS) 7-item questionnaire score of \>8 (low or moderate adherence) * Current use of albuterol metered dose inhaler (MDI) for rescue: ProAir, Ventolin, albuterol sulfate (from Prasco or Teva) * Uncontrolled asthma: * Symptomatic asthma defined as 3 of the following in the past 4 weeks: * Daytime symptoms of asthma more than twice per week * Any night awakening due to asthma * Rescue inhaler use for symptoms more than twice per week * Any activity limitation due to asthma; OR * Asthma Control Test score ≤19 * Has iPhone or Android smart phone with Short Message Service (SMS) * Has access to reliable WiFi service and a device with capability for telemedicine study visits * Ability to understand and willingness to sign consent documents * Evidence of Propeller sensor connection in the 4-week run-in period Exclusion Criteria: * Use of an investigational treatment in the previous 30 days. * Previous enrollment in MATCH Structured Interviews ( Aim 1) * Currently enrolled in an intervention trial * Currently uses an ICS not compatible with the Propeller sensor * Inability to comply with study procedures, including: * Inability or unwillingness to provide informed consent (or assent in the case of a minor). * Inability to perform study measurements. * inability to be contacted by phone via calls and /or text messaging * Not willing to have video chat * Any condition(s) in the opinion of the physician that puts the participant at risk from participating in the study